" class="no-js "lang="en-US"> Lars Prestegarden - Medtech Alert
Thursday, August 14, 2025
Lars Prestegarden

Lars Prestegarden

About Lars Prestegarden

Related Story

Cytovation Raises $20 Million in Series A Financing Round to Advance Clinical Development of CyPep-1, a First-in-Class Targeted Tumor Membrane Immunotherapy

January 25 2022

Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted […]